You are here

  • Home
  • Archive
  • Volume 34, Issue Suppl 3
  • EV032/#1256  Triple blinded prospective study assessing the impact of genomics & artificial intelligence Watson for oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma

Citation Tools

Article menu

Download PDFPDF

E-Poster Viewing Abstracts
AS02. Breast cancer
EV032/#1256  Triple blinded prospective study assessing the impact of genomics & artificial intelligence Watson for oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rohit Kumar C, Prasanna Somashekhar S, Yethadka R, et al
EV032/#1256  Triple blinded prospective study assessing the impact of genomics & artificial intelligence Watson for oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma
International Journal of Gynecologic Cancer 2024;34:A99.